Log in Register

Anti-CD22 [RFB-4]


Catalogue Number 151335
Applications FACS IHC IF
Antigen/Gene or Protein Targets CD22
Reactivity Human
Relevance Establishing origin of B cell malignancies, especially discriminating between immature (bone marrow type) and peripheral B cell leukaemias and lymphomas. Suitable for use as an immunotoxin against human B cell leukaemias and lymphomas.
Host Mouse
Immunogen Tonsil lymphocytes
Subclass IgG1
Molecular Weight (kDa) 153
Myeloma Used P3X63Ag8
Recommended Growing Conditions DMEM + 5% FCS
Strain Balb/c
Notes Cytoplasmic antigen of mature B lymphocytes. >90% reactivity on peripheral B cells.
Research Area Adhesion, Cancer, Cell Signaling & Signal Transduction, Immunology, Stem Cell Biology

References: 4 entries

DiJoseph et al. 2006. Clin Cancer Res. 12(1):242-9. PMID: 16397048.

Shen et al. 1988. Int J Cancer. 42(5):792-7. PMID: 3263328.

Bofill et al. 1985. J Immunol. 134(3):1531-8. PMID: 3871452.

Campana et al. 1985. J Immunol. 134(3):1524-30. PMID: 3918103.

Add a reference

This reagent does not have any reviews at the moment.